Medical Condition News

RSS

Researchers explore the clinical use of intravenous infusions of ketamine to treat depression

Depression is the most common mental illness as well as the number one cause of disability among people between the ages of 15 and 44. And for millions of sufferers, antidepressants have literally saved lives that could otherwise have been lost to suicide.

29 Sep 2021

Heart healthy adults have lower lifetime risk of type 2 diabetes

Heart healthy middle-aged adults are less likely to develop type 2 diabetes during their lifetime, according to a study published on World Heart Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology.

29 Sep 2021

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Oncotarget published "Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma" which reported that Multiple Myeloma patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses.

29 Sep 2021

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Chances are, the COVID-19 pandemic has affected your health — even if you have never been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to new research from Harvard Medical School, the stress of isolation from lockdown and stay-at-home measures is making people sick.

29 Sep 2021

Combination of two drugs may help pancreatic and liver cancer patients

A drug candidate discovered and developed decades ago in the laboratory of UC Davis distinguished professor Bruce Hammock may help control the body's raging and often deadly inflammatory response to chemotherapy treatments, especially for pancreatic and liver cancer patients.

29 Sep 2021

AIHW report: 1.2 million Australian adults affected by heart, stroke or vascular disease

A new report from the Australian Institute of Health and Welfare shows that 1.2 million Australian adults had one or more conditions related to heart, stroke or vascular disease in 2017–18.

29 Sep 2021

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

A new research study at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.

29 Sep 2021

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia.

28 Sep 2021

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Adults with type 1 diabetes need to be extra cautious of COVID-19 as they are more likely to be hospitalized and die, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

28 Sep 2021

Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease

Several studies conducted over the last decade have concluded that dry eye disease (DED) affects up to 50% of the U.S. population, creating a liability for the nation's health care system that is estimated to exceed $50 billion annually.

28 Sep 2021

Females more likely to report depressive symptoms than males in late life

Depression affects up to one in four people but is often associated with young adults in the public consciousness.

28 Sep 2021

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

A new study discusses the epidemiology of the outbreak in German nursing homes and the preventive measures undertaken.

28 Sep 2021

Depression in early adulthood may lead to cognitive decline in old age

While research has shown that poor cardiovascular health can damage blood flow to the brain increasing the risk for dementia, a new study led by UC San Francisco indicates that poor mental health may also take its toll on cognition.

28 Sep 2021

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

28 Sep 2021

Novel mind-body intervention found to be highly beneficial for treating chronic back pain

Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.

28 Sep 2021

BostonGene and MD Anderson collaborate to advance the development of multiplatform biomarker signatures

The University of Texas MD Anderson Cancer Center and BostonGene Corporation today announced a strategic alliance to advance the development and clinical integration of multiplatform biomarker signatures.

28 Sep 2021

Mass Eye and Ear researcher receives P50 NIH grant to establish new center for neurological voice disorders

Kristina Simonyan, MD, PhD, Dr med, director of laryngology research at Mass Eye and Ear, has been awarded an $11.9 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communicable Disorders of the National Institute of Health to form a new multidisciplinary center across four academic medical institutions that will be committed to conducting research on laryngeal dystonia and voice tremor, two debilitating neurological voice disorders.

28 Sep 2021

Medical Condition News

Researchers explore the clinical use of intravenous infusions of ketamine to treat depression

Heart healthy adults have lower lifetime risk of type 2 diabetes

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Combination of two drugs may help pancreatic and liver cancer patients

AIHW report: 1.2 million Australian adults affected by heart, stroke or vascular disease

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

People over 40 with type 1 diabetes have worse outcomes from COVID-19, shows study

Clinical study tests novel topical corneal epithelial stem cell-derived product for treating dry eye disease

Females more likely to report depressive symptoms than males in late life

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

Depression in early adulthood may lead to cognitive decline in old age

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

Novel mind-body intervention found to be highly beneficial for treating chronic back pain

BostonGene and MD Anderson collaborate to advance the development of multiplatform biomarker signatures

Mass Eye and Ear researcher receives P50 NIH grant to establish new center for neurological voice disorders

Salt substitutes are effective in reducing stroke, major cardiovascular events

Feeling happy about life reduces the odds of cognitive impairment in older adults

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News